Issued Patents 2016
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9492540 | Methods for treating cancer using anti-PD-1 antibodies | Alan J. Korman, Mohan Srinivasan, Changyu Wang, Mark J. Selby, Bingliang Chen +1 more | 2016-11-15 |
| 9492539 | Monoclonal antibodies to Programmed Death 1 (PD-1) | Alan J. Korman, Mohan Srinivasan, Changyu Wang, Mark J. Selby, Bingliang Chen +1 more | 2016-11-15 |
| 9429581 | IP-10 antibody dosage escalation regimens | Allison Y. Luo, Wendy L. Trigona, Jinshan Shen, Li Xu, Yan Zhang +4 more | 2016-08-30 |
| 9387247 | Monoclonal antibodies to programmed death 1 (PD-1) | Alan J. Korman, Mohan Srinivasan, Changyu Wang, Mark J. Selby, Bingliang Chen +1 more | 2016-07-12 |
| 9358289 | Methods for treating cancer using anti-PD-1 antibodies in combination with anti-CTLA-4 antibodies | Alan J. Korman, Mohan Srinivasan, Changyu Wang, Mark J. Selby, Bingliang Chen +1 more | 2016-06-07 |
| 9296822 | Human monoclonal antibodies to O8E | Alan J. Korman, Mark J. Selby, Li-Sheng Lu, Alison Witte | 2016-03-29 |
| 9273135 | Human monoclonal antibodies to programmed death ligand 1 (PD-L1) | Alan J. Korman, Mark J. Selby, Changyu Wang, Mohan Srinivasan, David B. Passmore +1 more | 2016-03-01 |
| 9266945 | Human anti-B7RP1 neutralizing antibodies | Gerald Siu, Wenyan Shen, Steven Kiyoshi Yoshinaga | 2016-02-23 |
| 9260514 | Methods of treating conditions caused by increased expression of nerve growth factor (NGF) or increased sensitivity to NGF using anti-NGF neutralizing antibodies as selective NGF pathway inhibitors | Kenneth D. Wild, Jr., James Treanor, Heather Inoue, Tie J. Zhang, Frank Martin | 2016-02-16 |
| 9228016 | Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof | Changyu Wang, Nils Lonberg, Alan J. Korman, Mark J. Selby, Mohan Srinivasan +7 more | 2016-01-05 |